Rubius Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(0.329%),Abigail P. Johnson(0.329%)
Rubius Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(0%)
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Noubar B. Afeyan, Ph.D.(42.7%),Flagship Ventures Fund IV General Partner LLC(26.8%), etc.
Rubius Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Abigail P. Johnson(13.694%),FMR LLC(13.694%)
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(5.39%)
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Schaffert Susanne
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
Rubius Therapeutics | 4: Statement of changes in beneficial ownership of securities
No Data
No Data